References
- Woolf CJ, Salter MW. Neuronal plasticity: increasing the gain in pain. Science 2000;288:1765-9
- Varrassi G, Müller-Schwefe G, Pergolizzi J, et al. Pharmacological treatment of chronic pain – the need for CHANGE. Curr Med Res Opin 2010;26:1055-69
- Müller-Schwefe G, Jaksch W, Morlion B, et al. Make a CHANGE: optimising communication and pain management decisions. Curr Med Res Opin 2010;27:481-8
- Woolf CJ, Mannion RJ. Neuropathic pain: aetiology, symptoms, mechanisms, and management. Lancet 1999;353:1959-64
- Woolf CJ, Max MB. Mechanism-based pain diagnosis: issues for analgesic drug development. Anesthesiology 2001;95:241-9
- Raffa RB, Pergolizzi JV, Tallarida RJ. The determination and application of fixed-dose analgesic combinations for treating multimodal pain. J Pain 2010;11:701-9
- Miller KE, Miller MM, Jolley MR. Challenges in pain management at the end of life. Am Fam Physician 2001;64:1227-34
- Weinstein SM. Physical examination. In: Ashburn MA, Rice LJ, eds. The Management of Pain. New York: Churchill Livingstone, 1998
- Lipman AG. Pharmacological approaches to pain management: nontraditional analgesics and analgesic adjuvants. In: Ashburn MA, Rice LJ, eds. The Management of Pain. New York: Churchill Livingstone, 1998
- Woolf CJ. Dissecting out mechanisms responsible for peripheral neuropathic pain: implications for diagnosis and therapy. Life Sci 2004;74:2605-10
- Freynhagen R, Baron R, Gockel U, et al. painDETECT: a new screening questionnaire to identify neuropathic components in patients with back pain. Curr Med Res Opin 2006;22:1911-20
- Ashburn M, Staats P. Management of chronic pain. Lancet 1999;353:1865-9
- Ballantyne JC, Mao JM. Opioid therapy for chronic pain. N Engl J Med 2003;349:1943-53
- Besson M, Piguet V, Dayer P, et al. New approaches to the pharmacotherapy of neuropathic pain. Expert Rev Clin Pharmacol 2008;1:683-93
- Raffa RB. Pharmacology of oral combination analgesics: rational therapy for pain. J Clin Pharm Ther 2001;26:257-64
- Raffa RB. Pharmacological aspects of successful long-term analgesia. Clin Rheumatol 2006;25:S9-S15
- Hanna M, O’Brien C, Wilson MC. Prolonged-release oxycodone enhances the effects of existing gabapentin therapy in painful diabetic neuropathy patients. Eur J Pain 2008;12:804-13
- Gilron I, Bailey JM, Tu D, et al. Morphine, gabapentin, or their combination for neuropathic pain. N Engl J Med 2005;352:2650-1
- Zin CS, Nissen LM, O’Callaghan JP, et al. A randomized, controlled trial of oxycodone versus placebo in patients with postherpetic neuralgia and painful diabetic neuropathy treated with pregabalin. J Pain 2010;11:462-71
- Clemens KE, Mikus G. Combined oral prolonged-release oxycodone and naloxone in opioid-induced bowel dysfunction: review of efficacy and safety data in the treatment of patients experiencing chronic pain. Expert Opin Pharmacother 2010;11:297-310
- Davis MP. What is new in neuropathic pain? Support Care Cancer 2007;15:363-72